论文信息 - PD-1 Blockade with the Monoclonal Antibody Pembrolizumab (MK-3475) in Patients with Classical Hodgkin Lymphoma after Brentuximab Vedotin Failure: Preliminary Results from a Phase 1b Study (KEYNOTE-013) - 字舞流文

PD-1 Blockade with the Monoclonal Antibody Pembrolizumab (MK-3475) in Patients with Classical Hodgkin Lymphoma after Brentuximab Vedotin Failure: Preliminary Results from a Phase 1b Study (KEYNOTE-013)

M. Shipp | P. Zinzani | G. Martinelli | P. Armand | V. Ribrag | M. Gutierrez | C. Moskowitz | J. Michot | S. Rose | E. Rubin | Joy X Wang | A. Jacob | Jennifer W. Anderson | M. Derosier | Karen M. Giallella | Guadalupe De Maeyer | Zijiang Yang